146 related articles for article (PubMed ID: 35646691)
1. Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation.
Wang T; Lv Z; Feng H; Li J; Cui B; Yang Y; Huang X; Zhang X; Li X; Ma X
Front Oncol; 2022; 12():860133. PubMed ID: 35646691
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic analysis of patients with T1 stage high grade of bladder urothelial carcinoma and glandular differentiation].
Wang C; Sun ZQ; Liu MY; Zhang JJ; Liu G; Feng Y; Yan YF; Cui HW; Li G
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):691-695. PubMed ID: 34289563
[No Abstract] [Full Text] [Related]
3. TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort.
Song SH; Lee J; Ko YH; Kim JW; Jung SI; Kang SH; Park J; Seo HK; Kim HJ; Jeong BC; Kim TH; Choi SY; Nam JK; Ku JY; Joo KJ; Jang WS; Yoon YE; Yun SJ; Hong SH; Oh JJ
Cancer Res Treat; 2023 Oct; 55(4):1337-1345. PubMed ID: 37080605
[TBL] [Abstract][Full Text] [Related]
4. Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis.
Zhao G; Wang C; Tang Y; Liu X; Liu Z; Li G; Mei Y
Sci Rep; 2019 Mar; 9(1):5323. PubMed ID: 30926888
[TBL] [Abstract][Full Text] [Related]
5. Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis.
Dutta R; Abdelhalim A; Martin JW; Vernez SL; Faltas B; Lotan Y; Youssef RF
Urol Oncol; 2016 Dec; 34(12):531.e1-531.e6. PubMed ID: 27427223
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
Flammia RS; Chierigo F; Würnschimmel C; Horlemann B; Hoeh B; Sorce G; Tian Z; Leonardo C; Tilki D; Terrone C; Saad F; Shariat SF; Montorsi F; Chun FK; Gallucci M; Karakiewicz PI
Urol Oncol; 2022 Apr; 40(4):165.e9-165.e15. PubMed ID: 34686429
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.
Mertens LS; Behrendt MA; Mehta AM; Stokkel L; de Jong J; Boot H; Horenblas S; van der Heijden MS; Moonen LM; Aalbers AGJ; Meinhardt W; van Rhijn BWG
Eur J Surg Oncol; 2019 Sep; 45(9):1740-1744. PubMed ID: 31003721
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
[TBL] [Abstract][Full Text] [Related]
9. Two Patients with Urachal Cancer with Multifocal Adenocarcinoma Recurrences in the Urothelium of the Prostatic and Penile Urethra.
Stokkel LE; van Montfoort ML; van Boven HH; Mertens LS; van Rhijn BWG
Eur Urol Open Sci; 2021 Nov; 33():56-60. PubMed ID: 34622223
[TBL] [Abstract][Full Text] [Related]
10. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
11. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
[TBL] [Abstract][Full Text] [Related]
14. Genetics and biological markers in urachal cancer.
Behrendt MA; van Rhijn BW
Transl Androl Urol; 2016 Oct; 5(5):655-661. PubMed ID: 27785422
[TBL] [Abstract][Full Text] [Related]
15. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
16. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
Wright JL; Porter MP; Li CI; Lange PH; Lin DW
Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
[TBL] [Abstract][Full Text] [Related]
17. Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder.
Xu H; Xie L; Liu X; Zhang Y; Shen Z; Chen T; Qiu X; Sha N; Xing C; Wu Z; Hu H; Wu C
Oncol Lett; 2017 Sep; 14(3):3522-3528. PubMed ID: 28927108
[TBL] [Abstract][Full Text] [Related]
18. Urachal cancer: contemporary review of the pathological, surgical, and prognostic aspects of this rare disease.
Behrendt MA; DE Jong J; VAN Rhijn BW
Minerva Urol Nefrol; 2016 Apr; 68(2):172-84. PubMed ID: 26583595
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
20. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
